{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:54:34Z","timestamp":1790405674718,"version":"4.1.0"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2010,2,1]],"date-time":"2010-02-01T00:00:00Z","timestamp":1264982400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1016\/j.bpobgyn.2009.08.010","type":"journal-article","created":{"date-parts":[[2009,10,31]],"date-time":"2009-10-31T08:57:11Z","timestamp":1256979431000},"page":"29-38","source":"Crossref","is-referenced-by-count":26,"title":["The use of hormonal contraception and its protective role against endometrial and ovarian cancer"],"prefix":"10.1016","volume":"24","author":[{"given":"Grigoris F.","family":"Grimbizis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basil C.","family":"Tarlatzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bpobgyn.2009.08.010_bib1","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S1470-2045(05)70273-4","article-title":"Carcinogeneity of combined oestrogen-progestagen contraceptives and menopausal treatment","volume":"6","author":"Cogliano","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.bpobgyn.2009.08.010_bib2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0140-6736(08)60142-7","article-title":"Ovarian cancer and oral contraceptives","volume":"371","author":"Franco","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2009.08.010_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(08)60139-7","article-title":"Editorial. The case for preventing ovarian cancer","volume":"371","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2009.08.010_bib4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(08)60167-1","article-title":"Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23257 women with ovarian cancer and 87303 controls","volume":"371","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2009.08.010_bib5","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1093\/humrep\/12.9.1851","article-title":"Risk of endometrial cancer in relation to use of combined oral contraceptives. A practitioner's guide to meta-analysis","volume":"12","author":"Schlesselman","year":"1997","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2009.08.010_bib6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/sj.bjc.6603260","article-title":"Oral contraceptive use and cancer. Findings in a large cohort study, 1968-2004","volume":"95","author":"Vessey","year":"2006","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bpobgyn.2009.08.010_bib7","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1136\/bmj.39289.649410.55","article-title":"Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study","volume":"335","author":"Hannaford","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.bpobgyn.2009.08.010_bib8","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/bjc.1995.260","article-title":"Endometrial and ovarian cancer and oral contraceptives-findings in a large cohort study","volume":"71","author":"Vessey","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bpobgyn.2009.08.010_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/01.cej.0000179274.24200.9d","article-title":"Oral contraceptives and ovarian cancer: an update","volume":"15","author":"La Vecchia","year":"2006","journal-title":"Eur J Cancer Prev"},{"key":"10.1016\/j.bpobgyn.2009.08.010_bib10","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1056\/NEJM199808133390702","article-title":"Oral contraceptives and the risk of hereditary ovarian cancer","volume":"339","author":"Narod","year":"1998","journal-title":"N Eng J Med"},{"key":"10.1016\/j.bpobgyn.2009.08.010_bib11","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1093\/aje\/kwh284","article-title":"Relation of contraceptive and reproductive history to ovarian cancer risk in carriers and non-carriers of BRCA1 gene mutations","volume":"160","author":"McGuire","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.bpobgyn.2009.08.010_bib12","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/sj.bjc.6602239","article-title":"Oral contraceptive use and ovarian cancer risk among carriers of BRCA1 and BRCA2 mutations","volume":"91","author":"Whittemore","year":"2004","journal-title":"Br J Cancer"},{"key":"10.1016\/j.bpobgyn.2009.08.010_bib13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJM200107263450401","article-title":"Parity, oral contraceptives andthe risk of ovarian cancer among carriers and non-carriers of a BRCA1 and BRCA2 mutation","volume":"345","author":"Modan","year":"2001","journal-title":"N Eng J Med"},{"key":"10.1016\/j.bpobgyn.2009.08.010_bib14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/aje\/152.3.233","article-title":"Risk of ovarian cancer in relation to estrogen and progestin dose and use characteristics of oral contraceptives","volume":"152","author":"Ness","year":"2000","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.bpobgyn.2009.08.010_bib15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation-a factor in ovarian neoplasia?","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2009.08.010_bib16","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S0140-6736(79)91435-1","article-title":"Incessant ovulation and ovarian cancer","author":"CasagrandeJT","year":"1979","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2009.08.010_bib17","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/0140-6736(91)93233-Y","article-title":"Incessant ovulation and ovarian cancer","volume":"337","author":"Lowry","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.bpobgyn.2009.08.010_bib18","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/cncr.2820710207","article-title":"The biology of ovarian cancer development","volume":"71","author":"Godwin","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.bpobgyn.2009.08.010_bib19","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/humupd\/1.3.284","article-title":"Ovarian stimulation and ovarian tumours: a cretical reappraisal","volume":"3","author":"Tarlatzis","year":"1995","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.bpobgyn.2009.08.010_bib20","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/humrep\/14.2.479","article-title":"Regression of endometrial hyperplasia after treatment with the gonadotrophin-releasing hormone analogue triptirelin: a prospective study","volume":"14","author":"Grimbizis","year":"1999","journal-title":"Hum Reprod"},{"key":"10.1016\/j.bpobgyn.2009.08.010_bib21","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/bjc.1988.44","article-title":"The dose-effect relationship between \"unopposed oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk","volume":"57","author":"Key","year":"1988","journal-title":"Br J Cancer"}],"container-title":["Best Practice & Research Clinical Obstetrics & Gynaecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693409001151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521693409001151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T16:56:20Z","timestamp":1544892980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521693409001151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,2]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["S1521693409001151"],"URL":"https:\/\/doi.org\/10.1016\/j.bpobgyn.2009.08.010","relation":{},"ISSN":["1521-6934"],"issn-type":[{"value":"1521-6934","type":"print"}],"subject":[],"published":{"date-parts":[[2010,2]]}}}